Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, announced today that it has entered into an asset purchase agreement with Amplyx Pharmaceuticals, an affiliate of Pfizer, to acquire the rights to fosmanogepix, a clinical-stage broad-spectrum antifungal candidate.
Tags :Lenz & Staehelin
Starrag and Tornos, the two traditional Swiss precision machine tool manufacturers, both listed at the SIX Swiss Exchange, announced on October 26, 2023 that they entered into a merger agreement. Under the terms of the merger, Tornos
Mablink Bioscience, a pre-clinical company pioneering the development of next-generation antibody-drug conjugates via its PSARLinkTM proprietary platform, announced an agreement to be acquired by Eli Lilly and Company. The biotechnology company is developing the next
Nadia Ohlhoff-Smahi Vice-President of the International Arbitration Commission AIJA
Nadia Ohlhoff-Smahi has been appointed Vice-President of the AIJA International Arbitration Commission with effect from 25 August 2023. Nadia is a senior associate in the Geneva office of Lenz & Staehelin, where she practices in the areas
On October 4, 2023, Novartis successfully executed the spin-off of Sandoz by distributing Sandoz shares as a dividend-in-kind to Novartis shareholders and American Depositary Receipts (ADRs) holders. Sandoz shares are now listed on the SIX Swiss Exchange.
Hans-Jakob Diem has joined Walder Wyss as partner as of 4 September 2023. Diem has been until its new incorporation, partner at Lenz & Staehelin at the Corporate and M&A practice group in Zurich, team
Lenz & Staehelin has successfully defended a Lebanese-owned telecommunications operator in proceedings before the Swiss Federal Supreme Court. The case involved the Republic of South Sudan’s attempt to annul an arbitral award issued in
Lenz & Staehelin presents its new corporate identity. At the centre is the new logo, which for the first time uses the tried and tested abbreviation L&S and graphically expresses how Lenz &
Latour Capital successfully completed its acquisition of Gutor Electronic from Schneider Electric SE. This transaction is part of Schneider Electric’s asset divestment plan. Headquartered in Wettingen, Switzerland, Gutor is the world leading manufacturer of
Paris-based private equity firm, Latour Capital, has successfully concluded its acquisition of Gutor Electronic from Schneider Electric. Gutor Electronic, headquartered in Wettingen, Switzerland, is a specialized manufacturer of Uninterruptible Power Supply (UPS) systems for